At UK£0.63, Is It Time To Put MYCELX Technologies Corporation (LON:MYX) On Your Watch List?
While MYCELX Technologies Corporation (LON:MYX) might not have the largest market cap around , it saw a significant share price rise of 45% in the past couple of months on the AIM. The recent share price gains has brought the company back closer to its yearly peak. Less-covered, small caps tend to present more of an opportunity for mispricing due to the lack of information available to the public, which can be a good thing. So, could the stock still be trading at a low price relative to its actual value? Today we will analyse the most recent data on MYCELX Technologies’s outlook and valuation to see if the opportunity still exists.
What's The Opportunity In MYCELX Technologies?
According to our price multiple model, which makes a comparison between the company's price-to-earnings ratio and the industry average, the stock price seems to be justfied. In this instance, we’ve used the price-to-earnings (PE) ratio given that there is not enough information to reliably forecast the stock’s cash flows. We find that MYCELX Technologies’s ratio of 24.72x is trading slightly above its industry peers’ ratio of 24.72x, which means if you buy MYCELX Technologies today, you’d be paying a relatively sensible price for it. And if you believe MYCELX Technologies should be trading in this range, then there isn’t really any room for the share price grow beyond the levels of other industry peers over the long-term. Is there another opportunity to buy low in the future? Since MYCELX Technologies’s share price is quite volatile, we could potentially see it sink lower (or rise higher) in the future, giving us another chance to buy. This is based on its high beta, which is a good indicator for how much the stock moves relative to the rest of the market.
Check out our latest analysis for MYCELX Technologies
What does the future of MYCELX Technologies look like?
Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. However, with an extremely negative double-digit change in profit expected next year, near-term growth is certainly not a driver of a buy decision. It seems like high uncertainty is on the cards for MYCELX Technologies, at least in the near future.
What This Means For You
Are you a shareholder? Currently, MYX appears to be trading around industry price multiples, but given the uncertainty from negative returns in the future, this could be the right time to de-risk your portfolio. Is your current exposure to the stock optimal for your total portfolio? And is the opportunity cost of holding a negative-outlook stock too high? Before you make a decision on MYX, take a look at whether its fundamentals have changed.
Are you a potential investor? If you’ve been keeping tabs on MYX for a while, now may not be the most optimal time to buy, given it is trading around industry price multiples. This means there’s less benefit from mispricing. Furthermore, the negative growth outlook increases the risk of holding the stock. However, there are also other important factors we haven’t considered today, which can help crystallize your views on MYX should the price fluctuate below the industry PE ratio.
If you want to dive deeper into MYCELX Technologies, you'd also look into what risks it is currently facing. To that end, you should learn about the 2 warning signs we've spotted with MYCELX Technologies (including 1 which is a bit concerning).
If you are no longer interested in MYCELX Technologies, you can use our free platform to see our list of over 50 other stocks with a high growth potential.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.